Free Trial

Stereotaxis (STXS) News Today

Stereotaxis logo
$1.98 +0.03 (+1.54%)
Closing price 03/25/2025 04:10 PM Eastern
Extended Trading
$2.02 +0.04 (+2.27%)
As of 03/25/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Stereotaxis says Nvidia highlighted technology at NVIDIA GTC
Stereotaxis (STXS) Gets a Buy from Lake Street
Stereotaxis, Inc. stock logo
Paul J. Isaac Acquires 38,000 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) Stock
Stereotaxis, Inc. (NYSEAMERICAN:STXS - Get Free Report) Director Paul J. Isaac purchased 38,000 shares of the company's stock in a transaction that occurred on Monday, March 10th. The shares were purchased at an average price of $1.81 per share, for a total transaction of $68,780.00. Following the completion of the transaction, the director now directly owns 87,299 shares of the company's stock, valued at $158,011.19. This represents a 77.08 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Stereotaxis, Inc. stock logo
Stereotaxis, Inc. (NYSEAMERICAN:STXS) Director Buys $42,171.19 in Stock
Stereotaxis, Inc. (NYSEAMERICAN:STXS - Get Free Report) Director Paul J. Isaac purchased 23,299 shares of the company's stock in a transaction on Thursday, March 6th. The shares were purchased at an average cost of $1.81 per share, with a total value of $42,171.19. Following the transaction, the director now directly owns 49,066 shares in the company, valued at $88,809.46. This trade represents a 90.42 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.
Stereotaxis to Present at 37th Annual Roth Conference
Stereotaxis, Inc. stock logo
Essex Investment Management Co. LLC Sells 197,165 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS)
Essex Investment Management Co. LLC trimmed its holdings in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) by 14.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,212,964 shares of the company's stock after sellin
Stereotaxis, Inc. stock logo
Q1 Earnings Estimate for Stereotaxis Issued By Roth Capital
Stereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) - Roth Capital cut their Q1 2025 earnings per share (EPS) estimates for shares of Stereotaxis in a report issued on Tuesday, March 4th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings of ($0.07) per share for the
Stereotaxis submits EMAGIN catheter for regulatory clearance
Stereotaxis sees double digit revenue growth for FY25
Stereotaxis Reports 2024 Full Year Financial Results
Stereotaxis Q4 2024 Earnings Preview
Stereotaxis, Inc. stock logo
Stereotaxis (STXS) to Release Earnings on Monday
Stereotaxis (NYSEAMERICAN:STXS) will be releasing earnings before the market opens on Monday, March 3. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=661839)
Stock Market Sleeps On Stereotaxis MAGiC CE Mark
Stereotaxis, Inc. stock logo
Legato Capital Management LLC Cuts Position in Stereotaxis, Inc. (NYSEAMERICAN:STXS)
Legato Capital Management LLC trimmed its position in Stereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) by 23.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 360,291 shares of the company's stoc
TD Cowen Keeps Their Buy Rating on Stereotaxis (STXS)
TD Cowen Reaffirms Their Buy Rating on Stereotaxis (STXS)
Stereotaxis Announces First GenesisX Robotic System Order
Stereotaxis receives CE Mark approval for MAGiC ablation catheter
Lake Street Remains a Buy on Stereotaxis (STXS)
Stereotaxis Hikes on Winning European Approval
Stereotaxis, Inc. stock logo
Traynor Capital Management Inc. Acquires Shares of 160,509 Stereotaxis, Inc. (NYSEAMERICAN:STXS)
Traynor Capital Management Inc. bought a new position in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 160,509 shares of the company's stock, valued
Stereotaxis announces Genesis RMN use by Oulu University Hospital
Stereotaxis, Inc. stock logo
Stereotaxis (NYSEAMERICAN:STXS) Shares Down 2.2% - Here's Why
Stereotaxis (NYSEAMERICAN:STXS) Stock Price Down 2.2% - Here's What Happened
Stereotaxis, Medtech announce catheter approved by China’s NMPA
Remove Ads
Get Stereotaxis News Delivered to You Automatically

Sign up to receive the latest news and ratings for STXS and its competitors with MarketBeat's FREE daily newsletter.

STXS Media Mentions By Week

STXS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

STXS
News Sentiment

0.50

0.77

Average
Medical
News Sentiment

STXS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

STXS Articles
This Week

5

2

STXS Articles
Average Week

Remove Ads
Get Stereotaxis News Delivered to You Automatically

Sign up to receive the latest news and ratings for STXS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSEAMERICAN:STXS) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners